期刊
EXPERT REVIEW OF NEUROTHERAPEUTICS
卷 18, 期 6, 页码 461-467出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/14737175.2018.1476140
关键词
Agitation; Alzheimer's disease; atypical antipsychotics; dementia; psychosis
Introduction: Antipsychotics have long been the mainstay of treatment for agitation and psychosis in Alzheimer's disease. Despite their current use successive studies have shown that they only confer a modest benefit which must be balanced against their well-established serious side effects (extrapyramidal symptoms, stroke, accelerated cognitive decline and mortality).Areas covered: This review outlines the current guidance on antipsychotic usage and the evidence of their continued usage against a backdrop of emerging pharmacological treatments and an increasing emphasis on the importance of non-pharmacological interventions.Expert commentary: The current justification for antipsychotic use in the context of the changing landscape of prescribing and provide a view on the most promising alternative candidates to this class of drug are appraised.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据